Bausch + Lomb: 3 Key Takeaways for Long-Term Investors

Bausch + Lomb reported Q3 2026 revenue growth of 8% to $1.375 billion, with adjusted EBITDA margins expanding to 23.6%, demonstrating operating leverage. The company reduced its net leverage ratio from 5.7x to 4.1x, moving closer to its 3.5x strategic target. Premium product adoption, particularly in intraocular lenses and dry eye therapies, is driving margin expansion faster than revenue growth, signaling strong pricing power.